Growth Hormone, Human: Clinical Trials

3 trials of Growth Hormone, Human, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

1 completed, 1 not yet recruiting, 1 recruiting. 2 Phase 1, 1 Not applicable.

By phase and status

PhaseTrialsStatus
Phase 12Completed 1, Not yet recruiting 1
Not applicable1Recruiting 1

Follow Growth Hormone, Human: new trials by email Literature Review of Growth Hormone, Human trials Research Report on Growth Hormone, Human

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Human Models of Selective Insulin Resistance: Pancreatic Clamp
Insulin human, Octreotide Acetate, Glucagon - Insulin Resistance, Hyperinsulinemia
Phase 1Not yet recruitingColumbia University362027-01-012026-02-06
Effects of Ketone Bodies on Insulin Sensitivity
Growth Hormone, Human, Oral ketone supplement (KetoAidĀ®, KE4), Saline infusion (placebo) - Insulin Resistance, Obesity & Overweight
Not applicableRecruitingUniversity of Aarhus102025-12-022026-01-22
Pancreatic Clamp in NAFLD
Insulin human, Octreotide Acetate, Glucagon - Insulin Resistance, Prediabetic State
Phase 1CompletedColumbia University182023-08-292026-01-12

Conditions studied

Insulin Resistance (3)  ·  Obesity (3)  ·  Diabetes Mellitus (2)  ·  Hyperinsulinism (2)  ·  Non-alcoholic Fatty Liver Disease (2)  ·  Prediabetic State (2)  ·  Overweight (1)

Sponsors

Columbia University (2)  ·  University of Aarhus (1)

Countries

United States (2)  ·  Denmark (1)

Top investigators

Joshua R Cook, MD, PhD (1)  ·  Joshua R. Cook, MD, PhD (1)

NIH funding

P30DK063608 (2), K12DK133995 (1)